Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance

Clinical Cancer Research

Volumn 11, Issue 9, 2005, Pages 3288-3295

  Chang, Hee Jin ^a   Yoo, Byong Chul ^a   Lim, Seok Byung ^a   Jeong, Seung Yong ^a   Kim, Woo Ho ^b   Park, Jae Gahb ^a,b  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

METABOTROPIC RECEPTOR 4;

ARTICLE; BLADDER EPITHELIUM; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER RECURRENCE; CANCER SURVIVAL; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SKIN EPITHELIUM; TUMOR DIFFERENTIATION; UPPER RESPIRATORY TRACT; UTERINE CERVIX EPITHELIUM;

AMINOBUTYRIC ACIDS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; RECEPTORS, METABOTROPIC GLUTAMATE; SURVIVAL ANALYSIS;

EID: 18244393785     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1912     Document Type: Article

References (31)

1. Tanabe Y, Masu M, Ishii T, Shigemoto R, et al. A family of metabotropic glutamate receptors. Neuron 1992; 8:169-79.
2. Aramori I, Nakanishi S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron 1992;8:757-65.
3. Skerry TM, Genever PG. Glutamate signalling in nonneuronal tissues. Trends Pharmacol Sci 2001;22: 174-81.
4. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108.
5. Komuro H, Rakic P. Modulation of neuronal migration by NMDA receptors. Science 1993;260:95-7.
6. Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 2001;98:6372-7.
7. Patton AJ, Genever PG, Birch MA, et al. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 1998; 22:645-9.
8. Genever PG, Maxfield SJ, Kennovin GD, et al. Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. J Invest Dermatol 1999;112: 337-42.
9. Brice NL, Varadi A, Ashcroft SJ, et al. Metabotropic glutamate and GABA(B) receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic β cells. Diabetologia 2002;45:242-52.
10. Pollock PM, Cohen-Solal K, Sood R, et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003; 34:108-12.
11. Takano T, Lin JH, Arcuino G, et al. Glutamate release promotes growth of malignant gliomas. Nat Med 2001;7:1010-5.
12. Yoo BC, Jeon EK, Hong SH, et al. Metabotropic glutamate receptor 4-mediated 5-fluorouracil resistance in human colon cancer cell line. Clin Cancer Res 2004;10:4176-84.
13. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In: Hamilton SR and Aaltonen LA, editors. WHO classification of tumors: pathology and genetics of tumors of the digestive system. Lyon (France): IARC Press; 2000. p. 103-41.
14. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. New York: Springer-Verlag; 2002.
15. Jeong SY, Shin KH, Shin JH, et al. Microsatellite instability and mutations in DNA mismatch repair genes in sporadic colorectal cancers. Dis Colon Rectum 2001; 46:1069-77.
16. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-56.
17. Nishio M, Koshikawa T, Kuroishi T, et al. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol 1996;14:497-502.
18. Park JG, Oie HK, Sugarbaker PH, et al. Characteristics of cell lines established from human colorectal carcinoma. Cancer Res 1987;47:6710-8.
19. Oh JH, Ku JL, Yoon KA, et al. Establishment and characterization of 12 human colorectal-carcinoma cell lines. Int J Cancer 1999;81:902-10.
20. Shannon HE, Sawyer BD. Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum. J Pharmacol Exp Ther 1989;251:518-23.
21. Sinsky M, Donnerer J. Evidence for a neurotransmitter role of glutamate in guinea pig myenteric plexus neurons. Neurosci Lett 1998;258:109-12.
22. Gill SS, Pulido OM, Mueller RW, et al. Immunochemical localization of the metabotropic glutamate receptors in the rat heart. Brain Res Bull 1999;48:143-6.
23. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001;53:1-24.
24. Dale LB, Babwah AV, Ferguson SS. Mechanisms of metabotropic glutamate receptor desensitization: role in the patterning of effector enzyme activation. Neurochem Int 2002;41:319-26.
25. Mundell SJ, Pula G, Carswell K, et al. Agonist-induced internalization of metabotropic glutamate receptor 1A: structural determinants for protein kinase C- and G protein-coupled receptor kinase-mediated internalization. J Neurochem 2003;842:294-304.
26. Borodezt K, D'Mello SR. Decreased expression of the metabotropic glutamate receptor-4 gene is associated with neuronal apoptosis. J Neurosci Res 1998; 53:531-41.
27. Choi SW, Park SY, Hong SP, et al. The expression of NMDA receptor1 is associated with clinicopathologic parameters and prognosis in the oral squamous cell carcinoma. J Oral Med Pathol 2004;33:533-7.
28. Peavy RD, Chang MS, Sanders-Bush E, et al. Metabotropic glutamate receptor 5-induced phosphorylation of extracellular signal-regulated kinase in astrocytes depends on transactivation of the epidermal growth factor receptor. J Neurosci 2001;21: 9619-28.
29. Iacovelli L, Bruno V, Salvatore L, et al. Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways. J Neurochem 2002;82: 216-23.
30. Thandi S, Blank JL, John Challiss RA. Group-1 metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J Neurochem 2002;83:1139-53.
31. Marinissen MJ, Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001;53:531-41.